Warning! GuruFocus detected
1 Severe warning sign
with NXEN.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Nexien BioPharma Inc
NAICS : 325412
SIC : 2834
ISIN : US46116E1038
Description
Nexien BioPharma Inc is a U.S.-based pharmaceutical company engaged in the formulation, development and commercialization of cannabinoid-based pharmaceuticals, in accordance with U.S. Food and Drug Administration ('FDA') pre-clinical and clinical pathways.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Equity-to-Asset | -423 | |||||
| Debt-to-Equity | -0.83 | |||||
| Debt-to-EBITDA | -2.93 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 60.7 | |||||
| 3-Year EPS without NRI Growth Rate | 48.9 | |||||
| 3-Year FCF Growth Rate | 20.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 96.74 | |||||
| 9-Day RSI | 84.06 | |||||
| 14-Day RSI | 71.23 | |||||
| 3-1 Month Momentum % | 27.27 | |||||
| 6-1 Month Momentum % | -59.77 | |||||
| 12-1 Month Momentum % | -76.51 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -8.1 | |||||
| Shareholder Yield % | -8.24 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -3907.41 | |||||
| ROIC % | -39.4 | |||||
| 3-Year ROIIC % | 564.55 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -11.18 | |||||
| EV-to-EBITDA | -11.18 | |||||
| EV-to-FCF | -19.16 | |||||
| Earnings Yield (Greenblatt) % | -8.94 | |||||
| FCF Yield % | -7.06 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:NXEN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Nexien BioPharma Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.003 | ||
| Beta | -1.37 | ||
| 3-Year Sharpe Ratio | 0.12 | ||
| 3-Year Sortino Ratio | 0.22 | ||
| Volatility % | 210.19 | ||
| 14-Day RSI | 71.23 | ||
| 14-Day ATR ($) | 0.000571 | ||
| 20-Day SMA ($) | 0.01054 | ||
| 12-1 Month Momentum % | -76.51 | ||
| 52-Week Range ($) | 0.0041 - 0.0495 | ||
| Shares Outstanding (Mil) | 70.77 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Nexien BioPharma Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Nexien BioPharma Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Nexien BioPharma Inc Frequently Asked Questions
What is Nexien BioPharma Inc(NXEN)'s stock price today?
The current price of NXEN is $0.01. The 52 week high of NXEN is $0.05 and 52 week low is $0.00.
When is next earnings date of Nexien BioPharma Inc(NXEN)?
The next earnings date of Nexien BioPharma Inc(NXEN) is .
Does Nexien BioPharma Inc(NXEN) pay dividends? If so, how much?
Nexien BioPharma Inc(NXEN) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers